Literature DB >> 2823229

Tissue-specific expression of the human alpha 1-antitrypsin gene is controlled by multiple cis-regulatory elements.

R F Shen1, Y Li, R N Sifers, H Wang, C Hardick, S Y Tsai, S L Woo.   

Abstract

Human alpha 1-antitrypsin (AAT) is expressed in the liver, and a 318 bp fragment immediately flanking the CAP site of the gene was found to be sufficient to drive the expression of a reporter gene (CAT) specifically in hepatoma cells. The enhancing activity however, was orientation-dependent. The DNA fragment was separated into a distal region and a proximal region. A "core enhancer" sequence GTGGTTTC is present within the distal region and is capable of activity enhancement in both orientations when complemented by the proximal region in the sense orientation. The results strongly suggest that there are multiple cis-acting elements in the human AAT gene that confer cell specificity for its expression. Nuclear proteins prepared from the hepatoma cells bound specifically to the proximal region in a band-shifting assay that was resistant to competition by the globin promoter DNA. Foot-printing analysis showed a protected domain within the proximal region that contains a nearly perfect palindromic sequence TGGTTAATATTCACCA, which may be important in the regulation of AAT expression in the liver.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823229      PMCID: PMC306367          DOI: 10.1093/nar/15.20.8399

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  40 in total

1.  Nucleotide sequence analysis of the chloramphenicol resistance transposon Tn9.

Authors:  N K Alton; D Vapnek
Journal:  Nature       Date:  1979 Dec 20-27       Impact factor: 49.962

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978.

Authors:  D W Cox; A M Johnson; M K Fagerhol
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

4.  Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus.

Authors:  L A Laimins; G Khoury; C Gorman; B Howard; P Gruss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

5.  Differential expression of the members of the discoidin I multigene family during growth and development of Dictyostelium discoideum.

Authors:  J M Devine; A S Tsang; J G Williams
Journal:  Cell       Date:  1982-04       Impact factor: 41.582

6.  Cloning and sequence of cDNA coding for alpha 1-antitrypsin.

Authors:  K Kurachi; T Chandra; S J Degen; T T White; T L Marchioro; S L Woo; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

7.  A new method for determination of alpha-1-antitrypsin phenotypes using isoelectric focusing on polyacrylamide gel slabs.

Authors:  R C Allen; R A Harley; R C Talamo
Journal:  Am J Clin Pathol       Date:  1974-12       Impact factor: 2.493

8.  Multiple point mutations affecting the simian virus 40 enhancer.

Authors:  H Weiher; M König; P Gruss
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

9.  Deletions covering the putative promoter region of early mRNAs of simian virus 40 do not abolish T-antigen expression.

Authors:  C Benoist; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  19 in total

1.  Clinical application of somatic gene therapy in inborn errors of metabolism.

Authors:  F D Ledley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Homology between alpha 2(V) and alpha 1(III) collagen promoters and evidence for negatively acting elements in the alpha 2(V) first intron and 5' flanking sequences.

Authors:  D S Greenspan; S T Lee; B S Lee; G G Hoffman
Journal:  Gene Expr       Date:  1991-04

3.  Characterization of the gene and protein of the common alpha 1-antitrypsin normal M2 allele.

Authors:  T Nukiwa; M L Brantly; F Ogushi; G A Fells; R G Crystal
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

4.  Tissue-specificity of liver gene expression: a common liver-specific promoter element.

Authors:  W Kugler; U Wagner; G U Ryffel
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

5.  Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of the human alpha-fetoprotein and albumin genes.

Authors:  K Sawadaishi; T Morinaga; T Tamaoki
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

6.  Liver cell specific gene transcription in vitro: the promoter elements HP1 and TATA box are necessary and sufficient to generate a liver-specific promoter.

Authors:  G U Ryffel; W Kugler; U Wagner; M Kaling
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

7.  Multiple hepatic trans-acting factors are required for in vitro transcription of the human alpha-1-antitrypsin gene.

Authors:  Y Li; R F Shen; S Y Tsai; S L Woo
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

8.  Transcriptional promoter of the human alpha 1(V) collagen gene (COL5A1).

Authors:  S Lee; D S Greenspan
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  Developmental regulation of specific protein interactions with an enhancerlike binding site far upstream from the avian very-low-density apolipoprotein II gene.

Authors:  P A Hoodless; R N Roy; A K Ryan; R J Haché; M Z Vasa; R G Deeley
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

10.  Retroviral-mediated gene transfer and expression of human phenylalanine hydroxylase in primary mouse hepatocytes.

Authors:  H Peng; D Armentano; L MacKenzie-Graham; R F Shen; G Darlington; F D Ledley; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.